Australia markets close in 4 hours 12 minutes

Kura Oncology, Inc. (KURA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.55+0.01 (+0.08%)
At close: 04:00PM EDT
12.26 -0.29 (-2.31%)
After hours: 04:41PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 838.84M
Enterprise value 394.47M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.87
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.97

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 3-36.90%
S&P500 52-week change 3-16.03%
52-week high 321.10
52-week low 310.41
50-day moving average 314.97
200-day moving average 314.73

Share statistics

Avg vol (3-month) 3842.35k
Avg vol (10-day) 31.15M
Shares outstanding 566.89M
Implied shares outstanding 6N/A
Float 846.05M
% held by insiders 12.77%
% held by institutions 1106.11%
Shares short (30 Aug 2022) 48.12M
Short ratio (30 Aug 2022) 411.38
Short % of float (30 Aug 2022) 412.39%
Short % of shares outstanding (30 Aug 2022) 412.14%
Shares short (prior month 28 July 2022) 46.08M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-15.95%
Return on equity (ttm)-26.45%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -134.14M
Net income avi to common (ttm)-133.33M
Diluted EPS (ttm)-1.99
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)450.26M
Total cash per share (mrq)6.73
Total debt (mrq)5.89M
Total debt/equity (mrq)1.31
Current ratio (mrq)25.73
Book value per share (mrq)6.72

Cash flow statement

Operating cash flow (ttm)-110.48M
Levered free cash flow (ttm)-66.09M